Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Ocean (042660), Final Payment Date for KRW 363.3B Subsidiary Rights Offering Changed to ‘Undetermined’

Posted on December 30, 2024July 18, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Ocean (042660), Final Payment Date for KRW 363.3B Subsidiary Rights Offering Changed to ‘Undetermined’

Source Fact: Financial Supervisory Service DART / 2024-12-30

Disclosure Type: Decision on Paid-in Capital Increase (Major Management Matters of Subsidiaries)

💡 3-Second Summary

Regarding the KRW 363.3 billion rights offering by Hanwha Ocean’s U.S. subsidiary, the final payment date previously scheduled for December 31, 2024, has been removed, and the schedule has been changed to ‘Undetermined,’ with capital to be contributed based on business progress.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Amendment Details: Among the details regarding the decision on the rights offering of ‘Hanwha Ocean USA International LLC’ (a subsidiary of Hanwha Ocean), the final payment date and related statements have been amended.
  • Previous Final Payment Date: 2024-12-31
  • Revised Final Payment Date: Undetermined
  • Size of Capital Increase (Purpose of Funding): Total KRW 363.3B
    • Funds for acquisition of securities of other corporations: KRW 360.4B
    • Operating funds: KRW 2.9B
  • Method of Capital Increase: Shareholder-allocated rights offering (This transaction does not involve the issuance of new shares).
  • Subsidiary Status: The primary business is Maritime Service. As of the disclosure baseline, the total assets of the subsidiary are recorded as KRW 0, meaning its proportion against the controlling company’s consolidated total assets (KRW 13,944,800,000,000) is stated as 0%.
  • Financial Baseline: The figures for the purpose of funding were converted based on the foreign exchange rate of 1 USD = 1,371.00 KRW as of June 14, 2024. The final KRW-denominated amount may vary depending on the actual exchange rate at the time of the capital increase.
  • Additional Note: The disclosure does not explain the specific reasons for the schedule change, stating only that the capital increase will be carried out over time based on business progress during the relevant period, and an updated disclosure will be filed once the final closing date is confirmed.

📈 2. [Expert View: Significance for Investors]

This amendment disclosure indicates that the explicit deadline for the U.S. subsidiary’s rights offering has been removed, shifting the capital execution structure to be contingent on ‘business progress.’ According to the text, the capital contribution itself has not been canceled; rather, it specifies that the investment will be carried out over time in accordance with the progress of the business operations.

Investors should focus on the fact that the explicit final deadline for the investment has been removed. Since the disclosure does not mention any financial impacts or specific reasons for the timeline alteration, it is difficult for investors to definitively assume any disruption in capital procurement or specific financial advantages/disadvantages. Instead, the correct analytical approach is to objectively track the actual sequence of capital deployments and monitor future update filings when the final closing date becomes confirmed.

📝 Editor’s Comment (by K-STOCK Editor)

This update reveals that the final payment deadline for Hanwha Ocean’s rights offering targeting its U.S. subsidiary has been lifted and replaced with a conditional framework based on business progress. Because the payment date, which was previously set to a specific day, has become undetermined, readers need to take note that the operational pacing of this capital application has adjusted from the initial plan.

However, the original text does not state the precise background for this timeline shift. As a result, interpreting this abruptly as a positive or negative development should be strongly discouraged. Investors should treat the upcoming updated filing—slated to be issued ‘at the time the final closing date is confirmed’—as the primary checkpoint, and maintain an objective stance while observing the real sequence of capital deployments and the final schedule as the main variables.

📢 Disclaimers and Source Information

Source: This content has been newly structured and written based on official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Shipbuilding

Post navigation

Previous Post: [Disclosure] Hanwha Ocean 042660, Final Payment Date for KRW 363.3B Subsidiary Rights Offering Changed to ‘Undetermined’ and Authorized Shares Expanded
Next Post: [Disclosure] Isu Petasys (007660) Maintains “Unconfirmed” Stance on Scrapping ‘Jeio Acquisition’ Rumors; Prolonged Wait-and-See Amid Governance Storm

Related Posts

[Disclosure] Hanamicron (067310) Additional Listing via Private CB Conversion Semiconductors
[Disclosure] Celltrion (068270) Clarifies Media Reports on Domestic CAPEX: KRW 300B Final Product (DP) Plant in Yesan Remains Unconfirmed Disclosures
[Disclosure] Celltrion (068270) Decides to Acquire 546,747 Treasury Shares Worth KRW 100 Billion to Stabilize Share Price and Enhance Shareholder Value Disclosures
[Disclosure] Alteogen (196170) to List 40,820 Additional Common Shares Following Executive Stock Option Exercises Disclosures
[Disclosure] Hanwha Aerospace (012450) to Host Investor Relations (IR) Event for Overseas Institutional Investors in Singapore Starting February 25 Disclosures
[Disclosure] Samsung Biologics (207940) Pre-Announces H1 2026 Financial Results Publication for July 23 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme